ClinicalTrials.Veeva

Menu

Comparing the Radial Extracorporeal Shock Waves and Botulinum Toxin Injection for Spasticity

M

Mackay Memorial Hospital

Status

Completed

Conditions

Post-Stroke Upper Limb Spasticity

Treatments

Device: Shock Wave
Drug: Botulinum toxin A

Study type

Interventional

Funder types

Other

Identifiers

NCT03131791
16MMHIS066e

Details and patient eligibility

About

Botulinum toxin type A (BoNT-A) is widely used in the clinics to reduce spasticity and improve upper limb function for post-stroke patients. However, there were no studies to compare the effect of rESWT and BoNT-A injection for treatment on spasticity.

Full description

Botulinum toxin type A (BoNT-A) is widely used in the clinics to reduce spasticity and improve upper limb function for post-stroke patients. However, the treatments of BoNT-A injection are associated with high cost and invasive treatment. Recent studies have showed that radial extracorporeal shock wave (rESWT) is a novel, effective and safety treatment method for the spasticity. However, there were no studies to compare the effect of rESWT and BoNT-A injection for treatment on spasticity.

Enrollment

42 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Aged between 18-80 year-old
  2. The onset of stroke must be at least 6 months previously
  3. Spasticity measured as Modified Asthow Scale more(MAS) than 1+
  4. Signed informed consent form

Exclusion criteria

  1. Patients with marked contractures in the elbow and wrist (MAS>4)
  2. Resistant hypertension, coagulation disorders, malignant tumors, pregnancy, pacemakers, cognitive disorders
  3. Prior or planned treatment with phenol or alcohol nerve blocks, intrathecal baclofen, or BoNT-A injection within the six months preceding the study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

42 participants in 2 patient groups

shock wave
Experimental group
Description:
The interventions were focused in the hypertonic muscles of the upper limb of 3000 impulses, a pressure of 1.5 bar and frequency of 5Hz were used to treat the biceps brachii, flexor carpi ulnaris and flexor carpi radialis, mainly in the middle of the belly.
Treatment:
Device: Shock Wave
Botulinum toxin A
Experimental group
Description:
We performed BoNT-A 500 unit in 2cc 0.9% normal saline at biceps brachii, flexor carpi ulnaris and flexor carpi radialis, mainly in the middle of the belly.
Treatment:
Drug: Botulinum toxin A

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems